BFC Planning’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$476 Hold
5
– – ﹤0.01% 3289
2026
Q2
$555 Hold
5
– – ﹤0.01% 3241
2026
Q1
$435 Hold
5
– – ﹤0.01% 2874
2025
Q4
$535 Hold
5
– – ﹤0.01% 2917
2025
Q3
$505 Buy
+5
New +$464 ﹤0.01% 2747

Other funds holding RYTM

BFC Planning's RYTM Position: Q3 2026 in Review

BFC Planning held its Rhythm Pharmaceuticals (RYTM) position steady in Q3 2026 at 5 shares worth $476. The position accounts for ﹤0.01% of the portfolio, ranked #3289.

BFC Planning first reported a position in RYTM in Q3 2025 and has held it in 5 quarters since. The position peaked at $555 in Q2 2026. 239 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • BFC Planning held 5 shares of Rhythm Pharmaceuticals worth $476 as of Q3 2026.
  • BFC Planning left its Rhythm Pharmaceuticals share count unchanged in Q3 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3289 holding.
  • BFC Planning first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • BFC Planning's Rhythm Pharmaceuticals position peaked at $555 in Q2 2026.
  • 239 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.